Founder & Managing Director
CurrentProven Global Solutions for Purpose-Driven OrganizationsThe Arcady Group helps organizations and businesses address global health issues, enhance patient and disease management, and improve the effectiveness and the efficiency of health systems. We turn science into action – enhancing patient management and health system delivery in some of the world’s most challenging disease states and in some of the most health-care challenged regions of the world. Clients include: ♦ The Bill & Melinda Gates Foundation (As both consultant and multiple grantee of the Gates Foundation, focusing on patient management and medication adherence issues in Tuberculosis and HIV/AIDS in India, China, and Sub-Saharan Africa.) -- Leading the development of new, more scalable, more cost-effective technologies to monitor medication adherence and compile detailed dosing records to inform and enable differentiated care, -- Assisting in the large scale testing and demonstration in resource-limited settings of dosing history-informed differentiated care -- to both improve health outcomes and improve health system efficiency, -- Advocating for the use of adherence technologies as standard of care for TB patients in high burden regions, through engagement with the WHO, Global Fund, Stop TB Partnership, and other funding and implementing organizations.♦ Novartis Pharma (As Adherence Subject Matter Expert to Novartis' Digital Medicines, focusing on identifying digital solutions to enhance patient care and improve health outcomes across a range of disease states and patient demographics)♦ Medicines For All Institute (Virginia Commonwealth University School Of Engineering) (As Senior Adviser to this Gates Foundation grantee, assisting in global health engagement and in scaling up and commercializing M4ALL’s novel process to reduce manufacturing cost, reduce waste and environmental impact, and improve access to a wide range of global health treatments)